- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 2.62M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 2.69M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $591K |
| Capex | Q1 2026 · Mar 31, 2025 | $464K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $34.46M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $36.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $124.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $126.24M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $21.88M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $28.53M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $30.78M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $38.1M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $116.99M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $121.92M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $174.58M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $181.2M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.51 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.58 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $16.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$371K |
| Net Income | Q1 2026 · Mar 31, 2025 | $4.06M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $848K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $4.29M |
| Revenue | Q1 2026 · Mar 31, 2026 | $45.64M |
| Revenue | Q1 2026 · Mar 31, 2025 | $50.01M |